184 related articles for article (PubMed ID: 30903237)
1. Demographic and diagnostic profiles of older people with intellectual disability and prescription of antipsychotics.
Axmon A; Ahlström G; Gagnemo Persson R; Eberhard J
Soc Psychiatry Psychiatr Epidemiol; 2019 Aug; 54(8):937-944. PubMed ID: 30903237
[TBL] [Abstract][Full Text] [Related]
2. Prescription of pain medication among older cancer patients with and without an intellectual disability: a national register study.
Segerlantz M; Axmon A; Gagnemo Persson R; Brun E; Ahlström G
BMC Cancer; 2019 Nov; 19(1):1040. PubMed ID: 31684896
[TBL] [Abstract][Full Text] [Related]
3. Prescription of potentially inappropriate medications among older people with intellectual disability: a register study.
Axmon A; Sandberg M; Ahlström G; Midlöv P
BMC Pharmacol Toxicol; 2017 Oct; 18(1):68. PubMed ID: 29070067
[TBL] [Abstract][Full Text] [Related]
4. Fall-risk-increasing drugs and falls requiring health care among older people with intellectual disability in comparison with the general population: A register study.
Axmon A; Sandberg M; Ahlström G; Midlöv P
PLoS One; 2018; 13(6):e0199218. PubMed ID: 29920564
[TBL] [Abstract][Full Text] [Related]
5. Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia.
Axmon A; Kristensson J; Ahlström G; Midlöv P
Res Dev Disabil; 2017 Mar; 62():50-57. PubMed ID: 28110116
[TBL] [Abstract][Full Text] [Related]
6. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
de Kuijper GM; Hoekstra PJ
J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population.
Axmon A; El Mrayyan N; Eberhard J; Ahlström G
BMC Psychiatry; 2019 Aug; 19(1):238. PubMed ID: 31370823
[TBL] [Abstract][Full Text] [Related]
8. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
[TBL] [Abstract][Full Text] [Related]
9. Prescribing of antipsychotics in UK primary care: a cohort study.
Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
[TBL] [Abstract][Full Text] [Related]
11. Specialist psychiatric health care utilization among older people with intellectual disability - predictors and comparisons with the general population: a national register study.
Ahlström G; Axmon A; Sandberg M; Hultqvist J
BMC Psychiatry; 2020 Feb; 20(1):70. PubMed ID: 32066421
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric diagnoses in relation to severity of intellectual disability and challenging behaviors: a register study among older people.
Axmon A; Björne P; Nylander L; Ahlström G
Aging Ment Health; 2018 Oct; 22(10):1344-1350. PubMed ID: 28825845
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
14. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
[TBL] [Abstract][Full Text] [Related]
15. The occurrence of comorbidities with affective and anxiety disorders among older people with intellectual disability compared with the general population: a register study.
El Mrayyan N; Eberhard J; Ahlström G
BMC Psychiatry; 2019 Jun; 19(1):166. PubMed ID: 31159756
[TBL] [Abstract][Full Text] [Related]
16. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities.
Lunsky Y; Khuu W; Tadrous M; Vigod S; Cobigo V; Gomes T
Can J Psychiatry; 2018 Jun; 63(6):361-369. PubMed ID: 28830241
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric diagnoses in older people with intellectual disability in comparison with the general population: a register study.
Axmon A; Björne P; Nylander L; Ahlström G
Epidemiol Psychiatr Sci; 2018 Oct; 27(5):479-491. PubMed ID: 28228177
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and treatment of diabetes mellitus and hypertension among older adults with intellectual disability in comparison with the general population.
Axmon A; Ahlström G; Höglund P
BMC Geriatr; 2017 Nov; 17(1):272. PubMed ID: 29169334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
